NCT02254278 Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer Status COMPLETED Phase PHASE2
NCT02250872 Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury Status UNKNOWN Phase PHASE2/PHASE3
NCT02243436 Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT02236936 Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck Status TERMINATED Phase PHASE3
NCT02227940 Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02225405 Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT02221999 Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT02217956 Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma Status COMPLETED Phase PHASE1
NCT02215265 Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02212574 Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma Status TERMINATED Phase EARLY_PHASE1
NCT02205047 Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma Status COMPLETED Phase PHASE2
NCT02202772 Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02199418 Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT02196168 Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT02194738 Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) Status ACTIVE_NOT_RECRUITING Phase NA
NCT02194049 Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT02188615 Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT02177838 Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer Status TERMINATED Phase NA
NCT02177695 S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer Status COMPLETED Phase PHASE2
NCT02170090 Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3